Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)
INR 19.5
(-4.97%)
INR 19.5
(-4.97%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 778.37 Million INR | 3.83% |
| 2022 | 749.66 Million INR | 113.5% |
| 2021 | 351.12 Million INR | -1.39% |
| 2020 | 356.08 Million INR | 6.15% |
| 2019 | 335.45 Million INR | 18.16% |
| 2018 | 283.9 Million INR | 17.8% |
| 2017 | 241.01 Million INR | 27.27% |
| 2016 | 189.37 Million INR | 9.58% |
| 2015 | 172.81 Million INR | -5.63% |
| 2014 | 183.12 Million INR | 0.38% |
| 2013 | 182.42 Million INR | 34.73% |
| 2012 | 135.39 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 743.49 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 778.37 Million INR | 3.83% |
| 2023 Q4 | 778.37 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 749.66 Million INR | 0.0% |
| 2022 FY | 749.66 Million INR | 113.5% |
| 2022 Q2 | 314.25 Million INR | 0.0% |
| 2021 Q4 | 351.12 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 351.12 Million INR | -1.39% |
| 2021 Q2 | 353.99 Million INR | 0.0% |
| 2020 Q4 | 356.08 Million INR | 0.0% |
| 2020 FY | 356.08 Million INR | 6.15% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 356.8 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 FY | 335.45 Million INR | 18.16% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 335.45 Million INR | 0.0% |
| 2018 Q4 | 283.9 Million INR | 0.0% |
| 2018 Q2 | 239.42 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 283.9 Million INR | 17.8% |
| 2017 FY | 241.01 Million INR | 27.27% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 209.35 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q4 | 241.01 Million INR | 0.0% |
| 2016 Q1 | 170.5 Million INR | -1.34% |
| 2016 FY | 189.37 Million INR | 9.58% |
| 2016 Q4 | 189.37 Million INR | 10.39% |
| 2016 Q3 | 171.54 Million INR | -0.56% |
| 2016 Q2 | 172.51 Million INR | 1.18% |
| 2015 Q2 | 167.89 Million INR | -2.46% |
| 2015 FY | 172.81 Million INR | -5.63% |
| 2015 Q4 | 172.81 Million INR | 4.43% |
| 2015 Q3 | 165.48 Million INR | -1.44% |
| 2015 Q1 | 172.13 Million INR | -6.0% |
| 2014 Q4 | 183.12 Million INR | 2.82% |
| 2014 Q1 | 176.05 Million INR | -3.49% |
| 2014 FY | 183.12 Million INR | 0.38% |
| 2014 Q3 | 178.1 Million INR | -2.73% |
| 2014 Q2 | 183.1 Million INR | 4.0% |
| 2013 Q3 | 127.79 Million INR | -2.38% |
| 2013 Q4 | 182.42 Million INR | 42.75% |
| 2013 FY | 182.42 Million INR | 34.73% |
| 2013 Q2 | 130.9 Million INR | -2.08% |
| 2013 Q1 | 133.68 Million INR | -1.6% |
| 2012 Q4 | 135.84 Million INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 151.81 Million INR | 0.0% |
| 2012 FY | 135.39 Million INR | 0.0% |
| 2011 Q4 | 159.57 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| ANG Lifesciences India Limited | 2.42 Billion INR | 67.894% |
| Bacil Pharma Limited | 13.26 Million INR | -5769.625% |
| BDH Industries Limited | 934.11 Million INR | 16.673% |
| Beryl Drugs Limited | 174.86 Million INR | -345.117% |
| Cian Healthcare Limited | 1.61 Billion INR | 51.707% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | -498.048% |
| Deccan Health Care Limited | 1.08 Billion INR | 27.961% |
| DECIPHER LABS LIMITED | 336.33 Million INR | -131.43% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | 38.202% |
| Concord Drugs Limited | 588.06 Million INR | -32.362% |
| Gujarat Terce Laboratories Limited | 232.73 Million INR | -234.445% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | 64.798% |
| Hindustan Bio Sciences Limited | 33.74 Million INR | -2206.763% |
| Ishita Drugs and Industries Limited | 108.08 Million INR | -620.134% |
| Jenburkt Pharmaceuticals Limited | 1.65 Billion INR | 52.854% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | 22.137% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | 80.255% |
| Makers Laboratories Limited | 1.61 Billion INR | 51.731% |
| Medi-Caps Limited | 1.27 Billion INR | 38.848% |
| MedPlus Health Services Limited | 30.04 Billion INR | 97.41% |
| Panchsheel Organics Limited | 1.59 Billion INR | 51.063% |
| Parmax Pharma Limited | 176.12 Million INR | -341.939% |
| Parnax Lab Limited | 1.88 Billion INR | 58.765% |
| Patidar Buildcon Limited | 94.27 Million INR | -725.63% |
| Phaarmasia Limited | 314.47 Million INR | -147.512% |
| PRAVEG LIMITED | 3.64 Billion INR | 78.651% |
| Sunil Healthcare Limited | 1.58 Billion INR | 50.891% |
| Syschem (India) Limited | 1.64 Billion INR | 52.546% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | -79.326% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 93.229% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -4322.311% |
| Smruthi Organics Limited | 1.18 Billion INR | 34.143% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | -229.111% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | 72.508% |
| Trident Lifeline Limited | 870.76 Million INR | 10.61% |
| Transchem Limited | 763.18 Million INR | -1.99% |
| Trinity League India Limited | 32.38 Million INR | -2303.418% |
| Tyche Industries Limited | 1.36 Billion INR | 43.143% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | 45.444% |
| Vista Pharmaceuticals Limited | 579.79 Million INR | -34.251% |
| Vivanza Biosciences Limited | 195.01 Million INR | -299.136% |
| Zenith Healthcare Limited | 97.41 Million INR | -699.042% |
| Zenlabs Ethica Limited | 402.58 Million INR | -93.344% |
| Mercury Laboratories Limited | 679.57 Million INR | -14.538% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | -105.295% |
| Vasundhara Rasayans Limited | 373.03 Million INR | -108.662% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | 58.739% |
| Roopa Industries Limited | 647.82 Million INR | -20.152% |
| PANJON LTD. | 173.91 Million INR | -347.566% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | 14.784% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -718.27% |
| Anuh Pharma Limited | 4.45 Billion INR | 82.535% |
| Crestchem Limited | 71.44 Million INR | -989.515% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -790.289% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | -48.502% |
| Fredun Pharmaceuticals Limited | 3.07 Billion INR | 74.695% |
| Trimurthi Limited | 73.64 Million INR | -956.865% |
| Norris Medicines Limited | 141.87 Million INR | -448.639% |
| Veerhealth Care Limited | 281.16 Million INR | -176.835% |
| Lactose (India) Limited | 1 Billion INR | 22.734% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | -23.175% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | 68.894% |
| Gennex Laboratories Limited | 2.29 Billion INR | 66.156% |
| Denis Chem Lab Limited | 1.09 Billion INR | 28.818% |
| Colinz Laboratories Limited | 113.59 Million INR | -585.222% |
| Godavari Drugs Limited | 1.34 Billion INR | 42.237% |
| Zenotech Laboratories Limited | 1.06 Billion INR | 26.711% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | 54.464% |
| Bharat Parenterals Limited | 5.03 Billion INR | 84.551% |
| Coral Laboratories Limited | 2.05 Billion INR | 62.156% |
| Evoq Remedies Limited | 368.61 Million INR | -111.164% |
| Kerala Ayurveda Limited | 1.4 Billion INR | 44.756% |
| KOBO BIOTECH LIMITED | 713.93 Million INR | -9.025% |
| Natural Capsules Limited | 3.76 Billion INR | 79.328% |
| Auro Laboratories Limited | 852.67 Million INR | 8.715% |